Search

Your search keyword '"Rogaeva, Ekaterina A."' showing total 1,149 results

Search Constraints

Start Over You searched for: Author "Rogaeva, Ekaterina A." Remove constraint Author: "Rogaeva, Ekaterina A."
1,149 results on '"Rogaeva, Ekaterina A."'

Search Results

1. Investigation of the genetic aetiology of Lewy body diseases with and without dementia

2. 18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes

4. Functional connectivity changes in neurodegenerative biomarker-positive athletes with repeated concussions

5. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

6. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

7. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

8. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

9. Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

10. Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

11. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

12. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

13. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

14. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

15. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

16. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

17. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

18. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

19. Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia

21. Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

22. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

23. Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study

24. Analysis of shared heritability in common disorders of the brain

25. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study

26. Analysis of shared heritability in common disorders of the brain.

27. Multiple system atrophy with amyloid-β predominant Alzheimer’s disease neuropathologic change

28. MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease

29. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia:GENFI results

30. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

31. Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

32. Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases.

33. Spatial enrichment and genomic analyses reveal the link of NOMO1 with amyotrophic lateral sclerosis.

34. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

35. Single-nucleus multiomic atlas of frontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms

36. Neuroinflammatory biomarkers in neurodegenerative disease: Insights from the ONDRI Cohort

37. Association of low frequency variants with regional cortical grey matter volumes in genetic frontotemporal dementia: Results from GENFI

38. Assessing the impact of falls on neuropsychiatric symptoms in patients with neurodegenerative disease

39. Association of low‐frequency and rare variants with cognition in genetic frontotemporal dementia: Results from GENFI

40. Corrigendum to: “Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member” [Stem Cell Res. 66 (2023) 1–5/102998]

42. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

44. Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals

45. Rarity of the Alzheimer Disease-Protective APP A673T Variant in the United States

47. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

48. The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint

49. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort

50. Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease

Catalog

Books, media, physical & digital resources